About us

Ai Mediq S.A. is a Helth BioMed tech company, headquartered in Luxembourg.

Company is focusing on development of therapeutic solutions based on individual cell protection mechanisms management following the concept of personalized medicine. Company developed and sells innovative hypoxic medical devices for treatment and rehabilitation of cardiovascular, neurological diseases and metabolic disorders.

Ai Mediq Group was founded in 2003 by a group of scientists in search of methods of preventive and preventativemedicine. The medical community has expressed a critical need for a device to provide interval hypoxia therapy for treating cardiovascular, neurological and metabolic diseases. A new treatment method has been developed, relevant patents registered and preclinical trials started.

In 2009, the company established its headquarters in Luxembourg and was officially incorporated as Ai Mediq S.A.

Ai Mediq S.A. began to develop a prototype for the new treatment method focused on screening analysis and biofeedback (SRT-Technology). This technology automatically adjusts procedure parameters in response to alterations in SpO2 and pulse oximeter heart rate readouts during the whole procedure.

In 2012 Ai Mediq S.A. presented ReOxy breathing therapy device to an international audience during World Cardiological Congress 2012 in Dubai, UAE.

The company’s product offering continues to evolve and expand and is permanently focused on areas that are vital for the improvement of patient care.

Quality and safety

Ai Mediq provides a timely and effective control over every stage of production.

All our suppliers are certified in the EN ISO 13485 and ISO 9000:2000 standards.

We continuously monitor our suppliers to secure the highest achievable quality of the final product.

Every product and service Ai Mediq offers is compliant with the EN ISO 13485 International Standard and MDD regulations MDD (93/42 EEC); EN 60601-1 (safety) / EN 60601-1-2 (EMC) criteria.

Our products are highly effective and always safe.

ReOxy breathing therapy device is a device that was developed based on latest developments in medical devices and electronics.

ReOxy is manufactured by Bitmos GmbH and is CE marked and produced in full compliance to 93/42/EEC (Medical Devices Directive – MDD), facilitating high quality and safety of operation.

Every Ai Mediq employee and subcontractor is proud of the excellent quality of its products.

This helps us to meet and exceed our customers expectations.